Delivery Order SPE2DB22D3009-SPE2DB25FAS26

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D2007|SPE2DB25FH7YM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,320.95 Firm Fixed Price Delivery Order is for the supply of 30-count Lurasidone HCl 40mg tablets. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $3,901.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4566779715 LURASIDONE HCL 20 MG TABLET 500S, with a firm fixed price and an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAHA2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,130.06, is a Delivery Order for the supply of 4566770655 ! LURASIDONE HCL 40 MG TABLET 500S. The contract has an ultimate completion date of December 20, 2024 and is a Firm Fixed Price contract type. The place of performance is Conshohocken, PA...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAHM5, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,836.92 fixed-price delivery order is for the provision of 500 tablets of the pharmaceutical drug Lurasidone Hydrochloride 40 mg. The contract has an ultimate completion date of December 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.77 firm fixed-price delivery order is for the supply of 500 tablets of 20 mg Lurasidone HCl, a medication used to treat mental health conditions. The contract has an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,642.41, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), provides the government with LATUDA 60 MG TABLET 30S, a branded pharmaceutical product. The award has an ultimate completion date of August 17, 2022 and a pricing type of Firm Fixed Price. The contract does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,959.35 firm fixed-price delivery order is for the supply of LATUDA 80 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $11,689.31, is for the delivery of LATUDA 20 MG TABLET 30S, a medication, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of pharmaceutical products, primarily the medication Latuda 80 mg tablets, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a not-to-exceed ceiling value of $1,232.76. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 24, 2023. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FPD91) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,900.49 fixed-price contract provides the DLA with 4,566,975,733 tablets of the medication Latuda (120 mg) to support military healthcare programs. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAS26
    Delivery Order

This federal contract award, identified as SPE2DB22D3009|SPE2DB25FAS26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,537.88, is for the delivery of LURASIDONE HCL 120 MG TABLET 500S, a pharmaceutical product.

The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 26, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors.

The DLA is the funding agency for this contract, and as a Defense agency, it supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the procurement of essential pharmaceutical and medical supplies. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/27/25, 9:44 AM